|
|
Overview
Compugen's research and discovery efforts are focused on developing unique predictive biology capabilities, which utilize computational technologies and experimental processes, to obtain deeper understandings of life at the molecular level and to incorporate these understandings in the development of diagnostic and therapeutic discovery engines. In the past decade, Compugen has made significant discoveries in different fields related to multiple biological phenomena such as alternative splicing, RNA editing, naturally occurring antisense, gene fusion, pseudogenes and more.
We are now building on this accumulated knowledge to develop discovery platforms incorporating additional powerful and broadly applicable biological phenomena. Current areas of research include identification of novel GPCR peptide ligands, Disease Associated Conformation peptide blockers, Protein-Protein Interaction Blockers, peptides for intracellular drug delivery, targets for monoclonal antibodies, new indications for existing drugs, pathway kinetic simulation, drug response genomic markers, drug-induced toxicity biomarkers, immunoassay and nucleic acids diagnostics, and more. |
|